Lindane mediated induction of cytochrome P-450 mRNA in rat liver: studies with a nonradioactive cDNA probe
Related Experiment Video
Updated: Oct 16, 2026
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Abstract:
Effect of lindane on the induction of cytochrome P-450 mRNA in rat liver was studied using a biotinylated cDNA probe. Exposure to lindane resulted in an increase in the levels of P-450 mRNA. The observed increase in mRNA was maximal (5-6-fold) after 18 hr of lindane treatment and lesser (50%) than mediated by phenobarbital for the same duration.
Insights
Lindane exposure increases cytochrome P-450 messenger RNA (mRNA) in rat livers. This induction was significant after 18 hours but less potent than phenobarbital.
Area of Science:
- Biochemistry
- Toxicology
- Molecular Biology
Background:
- Cytochrome P-450 enzymes are crucial for metabolizing xenobiotics.
- Understanding how environmental toxins like lindane affect P-450 expression is vital for risk assessment.
Purpose of the Study:
- To investigate the impact of lindane on cytochrome P-450 mRNA levels in rat liver.
- To quantify the induction of P-450 mRNA following lindane exposure.
Main Methods:
- Rats were exposed to lindane.
- Liver tissue was analyzed for cytochrome P-450 mRNA levels.
- A biotinylated cDNA probe was used for detection.
Main Results:
- Lindane exposure led to a significant increase in cytochrome P-450 mRNA.
- The maximum induction (5-6 fold) occurred at 18 hours.
- Lindane's effect was approximately 50% of that induced by phenobarbital over the same period.
Conclusions:
- Lindane is an inducer of cytochrome P-450 mRNA in rat liver.
- The potency of lindane as an inducer is lower than that of phenobarbital.
More Related Videos
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018